An independent group of 20 international experts has issued a scathing analysis of the global response to the 2014-15 Ebola outbreak in West Africa.
Harvard Stem Cell Institute researchers have taken what they describe as “the first step toward a pill that can replace the treadmill” for the control of obesity.
Myelin, the electrical insulating material in the body long known to be essential for the fast transmission of impulses along the axons of nerve cells, is not as ubiquitous as thought, according to new work led by Professor Paola Arlotta.
A Harvard panel examined the problem of clinics around the world that provide stem cell treatments for intractable conditions. Although there is no medical evidence of the treatments’ effectiveness, such clinics have drawn thousands of patients from many countries.
Four words on a previously unknown papyrus fragment provide the first evidence that some early Christians believed Jesus had been married, a Harvard professor says.
Harvard names Richard McCullough of Carnegie Mellon University as the vice provost for research.
A consortium of scientists at 20 institutions, led by a principal faculty member at the Harvard Stem Cell Institute, has used stem cells to take a major step toward developing personalized medicine to treat Parkinson’s disease.
Harvard stem cell researchers have succeeded in reprogramming adult mouse skin cells directly into the type of motor neurons damaged in amyotrophic lateral sclerosis, best known as Lou Gehrig's disease, and spinal muscular atrophy.
Harvard stem cell researchers at Children’s Hospital Boston have taken two important steps toward development of a new way of treating melanoma, the most virulent form of skin cancer.
To mark the 10th anniversary of the publication of the Human Genome Map, Harvard President Drew Faust will host a panel discussion on the project next week (Feb. 22) in Sanders Theatre.
A group of Harvard Stem Cell Institute researchers has made such a significant leap forward in reprogramming human adult cells that HSCI co-director Douglas Melton said the institute will immediately begin using the new method to make patient- and disease-specific induced pluripotent stem cells, known as iPS cells.